Close Menu

NEW YORK – Advanced Biological Laboratories announced Thursday its UltraGene Combo2Screen SARS-CoV-2 test received CE-IVD marking. 

The real-time RT-PCR test targets the N gene and E gene regions of the SARS-CoV-2 genome and requires a nasopharyngeal swab specimen. The assay is compatible with "most automatic or manual RNA extraction methods," along with qPCR instruments with at least three channels, the Luxembourg-based company said. Its turnaround time is less than two hours.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

President Donald Trump announced the US would be leaving the World Health Organization, NBC News reports.

CDC head says a new analysis indicates earlier testing wouldn't have caught viral spread, NPR reports.

A study of Great Danes homes in on a genomic region linked to fearfulness.

In PLOS this week: gene expression and epigenetics of Indonesian populations, hookworm parasite secretome, and more.